These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. Pancera M; Wyatt R Virology; 2005 Feb; 332(1):145-56. PubMed ID: 15661147 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins. Grundner C; Li Y; Louder M; Mascola J; Yang X; Sodroski J; Wyatt R Virology; 2005 Jan; 331(1):33-46. PubMed ID: 15582651 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker. Yuan W; Bazick J; Sodroski J J Virol; 2006 Jul; 80(14):6725-37. PubMed ID: 16809278 [TBL] [Abstract][Full Text] [Related]
5. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop. Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999 [TBL] [Abstract][Full Text] [Related]
6. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs. Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945 [TBL] [Abstract][Full Text] [Related]
7. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646 [TBL] [Abstract][Full Text] [Related]
8. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. Li Y; Svehla K; Mathy NL; Voss G; Mascola JR; Wyatt R J Virol; 2006 Feb; 80(3):1414-26. PubMed ID: 16415019 [TBL] [Abstract][Full Text] [Related]
9. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724 [TBL] [Abstract][Full Text] [Related]
10. The antigenic structure of the HIV gp120 envelope glycoprotein. Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684 [TBL] [Abstract][Full Text] [Related]
12. Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity. Dey B; Pancera M; Svehla K; Shu Y; Xiang SH; Vainshtein J; Li Y; Sodroski J; Kwong PD; Mascola JR; Wyatt R J Virol; 2007 Jun; 81(11):5579-93. PubMed ID: 17360741 [TBL] [Abstract][Full Text] [Related]
13. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer. Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B J Virol; 2017 May; 91(10):. PubMed ID: 28250125 [TBL] [Abstract][Full Text] [Related]
14. GP120: target for neutralizing HIV-1 antibodies. Pantophlet R; Burton DR Annu Rev Immunol; 2006; 24():739-69. PubMed ID: 16551265 [TBL] [Abstract][Full Text] [Related]
15. [Structure, function and antigenicity of the HIV1 envelope glycoproteins]. Pancera M Virologie (Montrouge); 2005 Dec; 9(6):457-472. PubMed ID: 34732006 [TBL] [Abstract][Full Text] [Related]
16. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265 [TBL] [Abstract][Full Text] [Related]
17. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity. Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566 [TBL] [Abstract][Full Text] [Related]
18. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits. Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514 [TBL] [Abstract][Full Text] [Related]
19. Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure. Kovacs JM; Noeldeke E; Ha HJ; Peng H; Rits-Volloch S; Harrison SC; Chen B Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18542-7. PubMed ID: 25512514 [TBL] [Abstract][Full Text] [Related]
20. Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. Yang X; Lee J; Mahony EM; Kwong PD; Wyatt R; Sodroski J J Virol; 2002 May; 76(9):4634-42. PubMed ID: 11932429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]